Sanofi Group is a global healthcare business engaged in discovering, manufacturing and marketing pharmaceutical products with a view to improving the health of patients worldwide. The company is listed in Paris (EURONEXT: SAN) and New York (NYSE: SNY).
Polish members of the Sanofi Group include: Sanofi-Aventis Sp. z o.o.—a manufacturer of innovative and OTC drugs; Sanofi Pasteur—the world’s largest vaccine manufacturer; Zentiva—a leading manufacturer of generic drugs in Central and Eastern Europe; Nepentes Pharma—one of the key players in the dermocosmetics market; Genzyme—a manufacturer of medicines for rare diseases; and Merial—a global leader in the animal healthcare industry.
The Sanofi Group operates 112 manufacturing sites throughout the world, including one located in Rzeszów, Poland. The Sanofi Group employs almost 1000 people in Poland. According to IMS Health Polska, the Group occupies a prominent position in the Polish ranking of the biggest pharmaceutical companies.
Sanofi’s General Manager in Poland, Marynika Woroszylska-Sapieha, shares two very important concepts that showcase the situation in Poland, stating that: “The biggest obstacle to innovation in Poland is the threshold…
Some of the biggest stories coming out of the Central and Eastern European (CEE) region’s pharma industry, including the European Bank’s EUR 25 million investment in Pelion Group; the amendments…
With a geostrategic location and easy access to both Western Europe and the rest of the emerging Central and Eastern Europe (CEE) region, Poland represents the sixth largest pharma market…
Poland’s largest pharmaceutical company and leading generics manufacturer, Polpharma, is looking to expand its presence outside of the country’s borders. With a recent acquisition bid for former Sanofi European generics…
Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Polpharma’s bid for Zentiva, Richter’s acquisition of OC Distributors and MDD approval…
Some of the top stories emanating from Poland’s pharma industry, including Polish biotech Ryvu Therapeutics’ exclusive deal with Exelixis, the partnership between Polpharma and startup Pikralida on a promising epilepsy…
Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Poland’s most promising biotech start-ups, an interview with Zentiva CEO Nick Haggar,…
Every year, Polish news magazine Wprost publishes its ranking of the top 200 Polish companies across all industries. Here, we profile the top five pharma-related companies featured in the 2019 rankings.…
Reinier Schlatmann, Philips CEO in Central and Eastern Europe, talks about the strategic significance of Poland for the company and how the implementation of Philips’ strategy and its focus on…
Ewa Sek, general manager at ResMed Poland, explains the crucial role of ResMed in raising awareness on sleep apnea, COPD and other respiratory-related conditions in Poland and highlights the important…
Jan Kruk of Polish pharmaceutical logistics and distribution specialist, Cefarm, discusses the organization’s secrets of success, as well as the broader logistics and distribution landscape in Poland. As the president…
Arjo, formerly Arjo Huntleigh, has undergone a rebrand and established its first formal office in Poland in 2017. Konrad Pianko, president of the CEE region which includes over 22 countries,…
Dariusz Adamusiński, general manager of A&D Pharma’s Polish operations has a busy year ahead. A new warehouse in Poland, partnerships across the pharmaceutical spectrum coupled with new regulations are all…
See our Cookie Privacy Policy Here
